semaglutide and binge eating disorder Neurobiological Mechanisms Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Disorder: A Narrative Review Novel potential pharmacological approaches in

In a similar vein, a study published this summer showed that patients taking semaglutide had a significantly lower risk of seeking medical care or counseling for tobacco use compared to those on other anti-diabetes medications

Some are now FDA-approved for chronic weight management, including semaglutide 2.4 mg (Wegovy), tirzepatide (Zepbound), and liraglutide 3 mg (Saxenda)

This is particularly important for perimenopausal women, who are already at risk for age-related muscle loss.[7] Laboratory Monitoring and Safety Protocols Comprehensive laboratory monitoring is essential for safe and effective GLP-1 therapy

This approach backfires

& Kaderali, L